Rudresh Agarwal

Rudresh Agarwal

Active Director Director DIN 02834486
DIN 02834486 First appointment Dec 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Dec 2009
Shareholding value •••• Premium profile

About Rudresh Agarwal

Data last updated:

Rudresh Agarwal is a Director at R&G Healthcare Private Limited (since 2018), Director at Parzival Tech Private Limited (since 2018) and Designated Partner at Indovyom Llp (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Information Technology and Machinery and Equipment. The 2 current companies with reported revenue have a combined latest revenue of ₹1.55 Cr; the largest is R&G Healthcare Private Limited at ₹1.43 Cr (FY 2021). Earlier, Rudresh Agarwal was a Director at Hp Infratech Private Limited (2009–2011) and Director at Mahalakshmi Bright Steel Industries Private Limited (2011–2012).

DIN 02834486
Primary Designation Director
Industry Pharma
First Appointment 29 Dec 2009
Oldest Company Age 8 yrs
Largest company R&G Healthcare Private Limited · ₹1.43 Cr (FY 2021)
Combined revenue ₹1.55 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R&G Healthcare Private Limited U74999HR2018PTC073727
Director23 Apr 20182018₹1.43 Cr (FY 2021)Active
Parzival Tech Private Limited U74999HR2018PTC074069
Director15 May 20182018₹12 Lakh (FY 2022)Active
Indovyom Llp ACO-8121
Designated Partner02 Jun 20252025Active
Harsukh Indorock Private Limited U32909PN2025PTC238330
Director20 Feb 20252025Active
H.P. Auto India Private Limited U29309TN2020PTC135374
Director21 May 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hp Infratech Private Limited U45400DL2009PTC197374
Director29 Dec 20092009Active
Director16 May 20112011₹281 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
H.P. Auto India Private Limited
R&G Healthcare Private Limited
Parzival Tech Private Limited
Indovyom Llp
Premium access

Shareholding and investment profile for Rudresh Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rudresh Agarwal

Rudresh Agarwal currently holds 5 directorships: R&G Healthcare Private Limited (Director, since 23 Apr 2018, revenue ₹1.43 Cr (FY 2021)); Parzival Tech Private Limited (Director, since 15 May 2018, revenue ₹12 Lakh (FY 2022)); Indovyom Llp (Designated Partner, since 02 Jun 2025); Harsukh Indorock Private Limited (Director, since 20 Feb 2025); H.P. Auto India Private Limited (Director, since 21 May 2020).

Rudresh Agarwal was first appointed on 29 Dec 2009 as Director at Hp Infratech Private Limited. The most recent appointment on record is 02 Jun 2025 at Indovyom Llp.

The 2 current companies of Rudresh Agarwal that report revenue have a combined latest revenue of ₹1.55 Cr: R&G Healthcare Private Limited ₹1.43 Cr (FY 2021); Parzival Tech Private Limited ₹12 Lakh (FY 2022).

Rudresh Agarwal held 2 earlier board appointments: Hp Infratech Private Limited (Director, 29 Dec 2009 to 08 Nov 2011); Mahalakshmi Bright Steel Industries Private Limited (Director, 16 May 2011 to 05 May 2012).

The current boards of Rudresh Agarwal's companies include Anuradha Agarwal (R&G Healthcare Private Limited), Gaurav Kumar Jain (R&G Healthcare Private Limited), Ashok Kumar Agarwal (Indovyom Llp), Janmejoy Singh (Harsukh Indorock Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available